7,630 Shares in National Health Investors, Inc. $NHI Bought by IFM Investors Pty Ltd

IFM Investors Pty Ltd purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI) during the 1st quarter, HoldingsChannel reports. The firm purchased 7,630 shares of the real estate investment trust’s stock, valued at approximately $617,000.

Other hedge funds also recently bought and sold shares of the company. Principal Financial Group Inc. increased its position in shares of National Health Investors by 1.9% during the fourth quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock worth $127,386,000 after purchasing an additional 30,968 shares in the last quarter. Tudor Investment Corp ET AL boosted its position in shares of National Health Investors by 189.8% in the 3rd quarter. Tudor Investment Corp ET AL now owns 116,570 shares of the real estate investment trust’s stock valued at $9,267,000 after purchasing an additional 76,339 shares during the period. Aberdeen Group plc boosted its position in shares of National Health Investors by 73.7% in the 4th quarter. Aberdeen Group plc now owns 45,355 shares of the real estate investment trust’s stock valued at $3,464,000 after purchasing an additional 19,241 shares during the period. Sound Income Strategies LLC grew its stake in National Health Investors by 6.5% during the 4th quarter. Sound Income Strategies LLC now owns 256,898 shares of the real estate investment trust’s stock worth $20,595,000 after buying an additional 15,638 shares during the last quarter. Finally, M&T Bank Corp acquired a new position in National Health Investors during the fourth quarter worth approximately $2,996,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Performance

Shares of NHI opened at $77.44 on Monday. The stock has a market capitalization of $3.75 billion, a P/E ratio of 24.98, a P/E/G ratio of 3.48 and a beta of 0.51. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. National Health Investors, Inc. has a 1 year low of $67.94 and a 1 year high of $91.38. The company’s fifty day moving average is $74.27 and its two-hundred day moving average is $79.64.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is 118.71%.

Insider Activity

In other news, CEO D. Eric Mendelsohn purchased 1,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the acquisition, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 2.70% of the company’s stock.

Wall Street Analyst Weigh In

NHI has been the subject of a number of research reports. BMO Capital Markets reduced their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a report on Wednesday, April 22nd. Zacks Research cut shares of National Health Investors from a “hold” rating to a “strong sell” rating in a report on Thursday, June 25th. Wells Fargo & Company reduced their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Finally, Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $83.86.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.